Possible Role of Nanocarriers in Drug Delivery Against Cervical Cancer

Overview

Journal Nano Rev Exp

Specialty Biotechnology

Date 2018 Nov 10

PMID 30410707

Citations 10

Authors

Swati Gupta

Manish K Gupta

Affiliations

Soon will be listed here.

Abstract

Cervical cancer is the second most common cancer and the largest cancer killer among women in most developing countries including India. Although, various drugs have been developed for cervical cancer, treatment with these drugs often results in a number of undesirable side effects, toxicity and multidrug resistance (MDR). Also, the outcomes for cervical cancer patients remain poor after surgery and chemo radiation. A literature search (for drugs and delivery systems against cervical cancer) was performed on PubMed and through Google. The present review discuss about various methods including its current conventional treatment with special reference to recent advances in delivery systems encapsulating various anticancer drugs and natural plant products for targeting towards cervical cancer. The role of photothermal therapy, gene therapy and radiation therapy against cervical cancer is also discussed. Systemic/targeted drug delivery systems including liposomes, nanoparticles, hydrogels, dendrimers etc. and localized drug delivery systems like cervical patches, films, rings etc. are safer than the conventional chemotherapy which has further been proved by the several drug delivery systems undergoing clinical trials. Novel approaches for the aggressive treatment of cervical cancer will optimistically result in decreased side effects as well as toxicity, frequency of administration of existing drugs, to overcome MDR and to increase the survival rates.

Citing Articles

Electrospun Coaxial Polycaprolactone/Polyvinylpyrrolidone Fibers Containing Cisplatin: A Potential Local Chemotherapy Delivery System for Cervical Cancer Treatment.

Silva-Lopez M, Escobar-Barrios V, Alcantara-Quintana L Polymers (Basel). 2025; 17(5).

PMID: 40076128 PMC: 11902410. DOI: 10.3390/polym17050637.

Investigating new drugs from marine seaweed metabolites for cervical cancer therapy by molecular dynamic modeling approach.

Islam S, Ahmed S, Mahfuj S, Das G, Tareq M, Almehmadi M Sci Rep. 2025; 15(1):3866.

PMID: 39890793 PMC: 11785738. DOI: 10.1038/s41598-024-82043-0.

Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review.

Kumar N, Mangla M Cancer Chemother Pharmacol. 2025; 95(1):18.

PMID: 39754614 DOI: 10.1007/s00280-024-04747-4.

Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.

Saha I, Halder J, Rajwar T, Mahanty R, Pradhan D, Dash P AAPS PharmSciTech. 2024; 25(4):85.

PMID: 38605158 DOI: 10.1208/s12249-024-02801-1.

Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study.

Almasoudi H, Hakami M, Alhazmi A, Makkawi M, Alasmari S, Alghamdi Y Med Oncol. 2023; 40(8):218.

PMID: 37394519 DOI: 10.1007/s12032-023-02094-7.

References

Bai J, Liu Y, Jiang X . Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials. 2014; 35(22):5805-13. DOI: 10.1016/j.biomaterials.2014.04.008. View

Kaku M, Mathew A, Rajan B . Impact of socio-economic factors in delayed reporting and late-stage presentation among patients with cervix cancer in a major cancer hospital in South India. Asian Pac J Cancer Prev. 2009; 9(4):589-94. View

Langer R . Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc Chem Res. 2000; 33(2):94-101. DOI: 10.1021/ar9800993. View

Milrot E, Jackman A, Kniazhanski T, Gonen P, Flescher E, Sherman L . Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin. Cancer Lett. 2011; 319(1):31-8. DOI: 10.1016/j.canlet.2011.12.028. View

You B, Moon H, Han Y, Park W . Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis. Food Chem Toxicol. 2010; 48(5):1334-40. DOI: 10.1016/j.fct.2010.02.034. View

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

Chun C, Lee S, Kim S, Yang H, Song S . Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications. Biomaterials. 2009; 30(12):2349-60. DOI: 10.1016/j.biomaterials.2008.12.083. View

Punfa W, Yodkeeree S, Pitchakarn P, Ampasavate C, Limtrakul P . Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Acta Pharmacol Sin. 2012; 33(6):823-31. PMC: 4010380. DOI: 10.1038/aps.2012.34. View

Kniazhanski T, Jackman A, Heyfets A, Gonen P, Flescher E, Sherman L . Methyl jasmonate induces cell death with mixed characteristics of apoptosis and necrosis in cervical cancer cells. Cancer Lett. 2008; 271(1):34-46. DOI: 10.1016/j.canlet.2008.05.031. View

10.

Saltzman W, Olbricht W . Building drug delivery into tissue engineering. Nat Rev Drug Discov. 2002; 1(3):177-86. DOI: 10.1038/nrd744. View

11.

Sun L, Wu Q, Peng F, Liu L, Gong C . Strategies of polymeric nanoparticles for enhanced internalization in cancer therapy. Colloids Surf B Biointerfaces. 2015; 135:56-72. DOI: 10.1016/j.colsurfb.2015.07.013. View

12.

Wu W, Shen J, Banerjee P, Zhou S . Water-dispersible multifunctional hybrid nanogels for combined curcumin and photothermal therapy. Biomaterials. 2010; 32(2):598-609. DOI: 10.1016/j.biomaterials.2010.08.112. View

13.

Wang X, Jandl T, Dadachova E, Revskaya E . Effect of naive and radiolabeled rhTRAIL on the cervical cancer xenografts in mice. Ther Deliv. 2014; 5(2):139-47. DOI: 10.4155/tde.13.137. View

14.

Dixit N, Vaibhav K, Pandey R, Jain U, Katare O, Katyal A . Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Biomed Pharmacother. 2015; 69:1-10. DOI: 10.1016/j.biopha.2014.10.016. View

15.

Lu W, Zhang G, Zhang R, Flores 2nd L, Huang Q, Gelovani J . Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res. 2010; 70(8):3177-88. PMC: 2856125. DOI: 10.1158/0008-5472.CAN-09-3379. View

16.

Zhang C, Zhang Z, Zhao L . Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity. Drug Deliv. 2015; 23(5):1830-7. DOI: 10.3109/10717544.2015.1122675. View

17.

Ta T, Porter T . Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release. 2013; 169(1-2):112-25. PMC: 5127786. DOI: 10.1016/j.jconrel.2013.03.036. View

18.

Ditto A, Shah K, Robishaw N, Panzner M, Youngs W, Yun Y . The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow. Mol Pharm. 2012; 9(11):3089-98. PMC: 3518442. DOI: 10.1021/mp300221f. View

19.

Iwata M, Machida Y, Nagai T, Masuda H . Double-layered stick-type formulation of bleomycin for treatment of uterine cervical cancer. Drug Des Deliv. 1987; 1(3):253-60. View

20.

Zong S, Wang X, Yang Y, Wu W, Li H, Ma Y . The use of cisplatin-loaded mucoadhesive nanofibers for local chemotherapy of cervical cancers in mice. Eur J Pharm Biopharm. 2015; 93:127-35. DOI: 10.1016/j.ejpb.2015.03.029. View